Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending August 2012. The report details a specific share repurchase transaction executed on August 1, 2012, pursuant to shareholder authority granted at the Annual General Meeting on May 3, 2012.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. It focuses exclusively on capital structure and share repurchase activity.
- Shares Purchased: 900,000 Ordinary Shares of 25 pence each.
- Purchase Price Range: Highest price paid was 1,490 pence per share; lowest price paid was 1,468.5 pence per share.
- Treasury Holdings (Settled): 481,407,927 shares, representing 8.80% of total issued share capital.
- Treasury Holdings (Including Unsettled): 484,607,927 shares, representing 9.72% of current total voting rights.
- Shares in Issue (Excluding Treasury): 4,988,196,958 shares.
Material Changes
The primary material change reported is the reduction of outstanding shares through the purchase of 900,000 shares for Treasury. Consequently, the percentage of total voting rights held in Treasury increased to 9.72% when including unsettled purchases. The filing does not provide comparative data for prior periods regarding these specific metrics.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. It is a compliance announcement confirming conformity with the Financial Services Authority's Disclosure and Transparency Rules and explicitly states it does not constitute an offer to purchase or subscribe for securities.
Investor Verification Checklist
- Verify the total number of shares held in Treasury (481,407,927 settled) against the company's latest capitalization table.
- Confirm the denominator for voting rights calculations is 4,988,196,958 shares (excluding Treasury) for disclosure threshold assessments.
- Review the price paid (1,468.5 to 1,490 pence) against the market price on August 1, 2012, to assess execution efficiency.
- Check subsequent filings for the settlement status of the 3,200,000 shares mentioned as "purchased but not yet settled" in the context of the 9.72% voting rights figure.